PPT-1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa
Author : lindy-dunigan | Published Date : 2019-02-22
Update on Pharmaceutical Manufacturing Plan for Africa Dr Djoudalbaye Benjamin Senior Health Officer African Union Commission Presentation outline Definition
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "1 TRIPS and Public Health: Implications ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa: Transcript
Update on Pharmaceutical Manufacturing Plan for Africa Dr Djoudalbaye Benjamin Senior Health Officer African Union Commission Presentation outline Definition TRIPS Agreement TRIPS and Public Health. Prof. S K Verma. ISIL, New Delhi. Conference on IP Policy. Bangkok, . December 1, . 2013. Post-TRIPS: new vistas of IP protection. TRIPS Agreement –a most comprehensive multilateral agreement on intellectual property. Zambia. Presentation t. o Civil Society meeting. Lusaka. 1 Oc. tober. . 2013. Patents make medicines unaffordable!. Patents create monopolies and dependencies. Beneficial for R&D companies (in rich countries). Zimbabwe. Presentation t. o Civil Society meeting. Harare. 21 January. 2014. Patents make medicines unaffordable!. Patents create monopolies and dependencies. Beneficial for R&D companies (in rich countries). Dr. Boubacar Cisse. Marie Stopes International Mali. October 2014. . BlueStar Mali Overview. Start up - March 2011. Partial Franchise – FP + HIV. Network of 140 providers – 132 public providers – . project- . . BRCC-Andhra Pradesh. AP State Level Presentation. . by. . . Engineering Staff College of India. Hyderabad. Middle East and North Africa Health Policy Forum. Regional Conference 12-13 November, 2017. Regulation . of Public-Private Partnerships . to Advance Towards Universal Health Coverage. Dr. . Hala Abou . sector. . Cécile . Macé. Department of Essential Medicines and Health Products. English Technical Briefing Seminar. 30 October 2013. Ten leading causes of inefficiency. World Health Report 2010, Chapter 4. T.U. . Federation of Chemical, Glass and Ceramic. . Industries. . in Poland.. Józef Woźny- . President. National . Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses. . . July 2015, Nairobi . Kenya. Dr Amit N. Thakker. EAHP, Chairman. KHF, Director and CEO. . . About KHF. KHF is the Kenya Private Sector Alliance (KEPSA) umbrella health sector representative body . Yogan. . Pillay. National Department of Health, South Africa. July 24, 2014. HIV and ART in South Africa. 6.4 . million people living with HIV and . AIDS (total population 54 million). Prevalence amongst pregnant women: 29%. sector. . Cécile . Macé. Department of Essential Medicines and Health Products. English Technical Briefing Seminar. 30 October 2013. Ten leading causes of inefficiency. World Health Report 2010, Chapter 4. Presented by: Nimrod Muhumuza (Head of Research Department – Ahaki). Afya. . na. . Haki. Institute (Ahaki) . Plot 6105 Valley Road, Gayaza, Nakwero . P.O BOX 16617, Wandegeya - Kampala . Tel: +256- 41- 4660733 . ECA: . Useful analyses but need a rigorous standardization. Driss M. Zine-Eddine El-Idrissi, PhD, Lead Economist. Health Nutrition and Population GP, ECA. PEMPAL BCOP Plenary Conference – Ljubljana, Slovenia. Denis Kibira, PhD. National Coordinator . MeTA. -Uganda. CEO- DUMAIC Global Health. About . MeTA. & DUMAIC. MeTA. is a multi-stakeholder platform to improve access to health commodities.. We are a catalyst/driver for change..
Download Document
Here is the link to download the presentation.
"1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
